Novel CCR2 antagonists with a novel 2-aminooctahydrocyclopentalene-3a-carboxamide scaffold were designed. SAR studies led to a series of potent compounds. For example, compound 51 had a good PK profile in both dog and monkey, and exhibited excellent efficacy when dosed orally in an inflammation model in hCCR2 KI mice. In addition, an asymmetric synthesis to the core structures was developed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.10.069 | DOI Listing |
Publication Analysis
Top Keywords
ccr2 antagonists
8
antagonists novel
8
novel 2-aminooctahydrocyclopentalene-3a-carboxamides
4
2-aminooctahydrocyclopentalene-3a-carboxamides potent
4
potent ccr2
4
novel ccr2
4
novel 2-aminooctahydrocyclopentalene-3a-carboxamide
4
2-aminooctahydrocyclopentalene-3a-carboxamide scaffold
4
scaffold designed
4
designed sar
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!